Chrysalis Pharma AG in Liquidation
Company Overview
Previous Company Names
- Chrysalis Pharma AG
Management
Mark Hardy
Leighton Buzzard, GB
Chairperson of the board + liquidator
Individual signing authority
Johann Spleiss
Ziefen
Member of the board + liquidator
Individual signing authority
Thomas Tóth-von Kisker
Bottmingen
Member of the board + liquidator
Individual signing authority
Roland Bufton
Wilen (Sarnen)
President
Joint signing authority (any two to sign)
Johannes Spleiss
Ziefen
Member
Joint signing authority (any two to sign)
Peter Mathys
Allschwil
Member
Joint signing authority (any two to sign)
Roland Bufton
Monaco (MC)
President
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 799 | 26.07.2022 | 146 | 29.07.2022 | 1005531918 |
| 2 | 818 | 13.07.2020 | 136 | 16.07.2020 | 1004938329 |
| 3 | 750 | 25.06.2019 | 123 | 28.06.2019 | 1004662322 |
| 4 | 915 | 06.07.2016 | 132 | 11.07.2016 | 2944455 |
| 5 | 419 | 24.03.2016 | 62 | 31.03.2016 | 2751413 |
| 6 | 1180 | 18.09.2014 | 183 | 23.09.2014 | 1728729 |
| 7 | 1126 | 09.09.2014 | 176 | 12.09.2014 | 1711481 |
| 8 | 1265 | 06.09.2011 | 175 | 09.09.2011 | 6328194 |
| 9 | 84 | 17.01.2011 | 15 | 21.01.2011 | 13/5996748 |
| 10 | 786 | 07.05.2010 | 92 | 14.05.2010 | 13/5632590 |
Company Purpose
Die Gesellschaft bezweckt die Verwertung gewerblicher Schutzrechte im weitesten Sinn, insbesondere aus dem Bereich pharmazeutischer Produkte, sowie die Herstellung und den Vertrieb solcher Produkte. Nebenzwecke siehe Statuten.